Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in BIOCRYST PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 378,853 shares of BCRX (BIOCRYST PHARMACEUTICALS INC), worth $3M as of 2025-Q4. The position was decreased (-4.0% shares). BCRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$3M
Current Shares
378,853
Total Value Change
+$279,714
Total Shares Change
-54,050
Other major holders of BCRX: BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 378,853 |
-4.0% |
| $3M |
| 0.0% |
| $7.66 |
0 |
| 2025-Q3 | Decreased | 394,740 | -43.0% | $3M | 0.0% | $7.55 | 0 |
| 2025-Q2 | Increased | 691,969 | +54.3% | $6.2M | 0.0% | $9.36 | 38 |
| 2025-Q1 | Increased | 448,466 | +11.8% | $3.4M | 0.0% | $7.86 | 30 |
| 2024-Q4 | Increased | 401,111 | +3.0% | $3M | 0.0% | $7.53 | 27 |
| 2024-Q3 | Decreased | 389,530 | -10.0% | $3M | 0.0% | $7.62 | 0 |
| 2024-Q2 | Increased | 432,903 | +75.3% | $2.7M | 0.0% | $6.18 | 40 |